机构:[1]The First Affiliated Hospital of Jinan University, School of Stomatology, Clinical Research Platform for Interdiscipline of Stomatology, Jinan University, Guangzhou, 510630, People's Republic of China.[2]College of Pharmacy, Jinan University, Guangzhou, 510632, People's Republic of China.[3]Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, Jinan University, Guangzhou, 510632, People's Republic of China.
This work was generously supported by the National Natural Science Foundation of China (82201001), the Natural Science Foundation Projects of Guangdong (2021A1515010882), the Science and Technology Projects in Guangzhou (202102010040, 202201010315 and 2023A03J1030), and the Clinical Frontier Technology Program of the First Affiliated Hospital of Jinan University, China (JNU1AF-CFTP-2022-a01210).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|2 区医学
小类|2 区药学3 区纳米科技
最新[2025]版:
大类|2 区医学
小类|2 区药学3 区纳米科技
第一作者:
第一作者机构:[1]The First Affiliated Hospital of Jinan University, School of Stomatology, Clinical Research Platform for Interdiscipline of Stomatology, Jinan University, Guangzhou, 510630, People's Republic of China.
共同第一作者:
通讯作者:
通讯机构:[1]The First Affiliated Hospital of Jinan University, School of Stomatology, Clinical Research Platform for Interdiscipline of Stomatology, Jinan University, Guangzhou, 510630, People's Republic of China.[2]College of Pharmacy, Jinan University, Guangzhou, 510632, People's Republic of China.[3]Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, Jinan University, Guangzhou, 510632, People's Republic of China.[*1]The First Affiliated Hospital of Jinan University, School of Stomatology, Clinical Research Platform for Interdiscipline of Stomatology, Jinan University, Guangzhou, 510630, People’s Republic of China[*2]College of Pharmacy, Jinan University, Guangzhou, 510632, People’s Republic of China
推荐引用方式(GB/T 7714):
Cai Mingxiang,Peng Huizhen,Liu Minyi,et al.Vascular Pericyte-Derived Exosomes Inhibit Bone Resorption via Traf3[J].International Journal Of Nanomedicine.2023,18:7065-7077.doi:10.2147/IJN.S438229.
APA:
Cai Mingxiang,Peng Huizhen,Liu Minyi,Huang Maohua,Zheng Wen...&Liu Xiangning.(2023).Vascular Pericyte-Derived Exosomes Inhibit Bone Resorption via Traf3.International Journal Of Nanomedicine,18,
MLA:
Cai Mingxiang,et al."Vascular Pericyte-Derived Exosomes Inhibit Bone Resorption via Traf3".International Journal Of Nanomedicine 18.(2023):7065-7077